Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Operating Leases (2021 - 2025)

Organogenesis Holdings has reported Operating Leases over the past 5 years, most recently at $22.5 million for Q4 2025.

  • Quarterly results put Operating Leases at $22.5 million for Q4 2025, down 10.83% from a year ago — trailing twelve months through Dec 2025 was $22.5 million (down 10.83% YoY), and the annual figure for FY2025 was $22.5 million, down 10.83%.
  • Operating Leases for Q4 2025 was $22.5 million at Organogenesis Holdings, down from $23.5 million in the prior quarter.
  • Over the last five years, Operating Leases for ORGO hit a ceiling of $57.1 million in Q1 2021 and a floor of $20.9 million in Q4 2022.
  • Median Operating Leases over the past 5 years was $25.1 million (2023), compared with a mean of $32.1 million.
  • Peak annual rise in Operating Leases hit 80.4% in 2022, while the deepest fall reached 55.33% in 2022.
  • Organogenesis Holdings' Operating Leases stood at $46.9 million in 2021, then tumbled by 55.33% to $20.9 million in 2022, then rose by 19.6% to $25.1 million in 2023, then grew by 0.58% to $25.2 million in 2024, then fell by 10.83% to $22.5 million in 2025.
  • The last three reported values for Operating Leases were $22.5 million (Q4 2025), $23.5 million (Q3 2025), and $24.6 million (Q2 2025) per Business Quant data.